Virginia Cancer Specialists Revenue and Competitors

Merrifield, VA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Virginia Cancer Specialists's estimated annual revenue is currently $122.2M per year.(i)
  • Virginia Cancer Specialists's estimated revenue per employee is $337,500

Employee Data

  • Virginia Cancer Specialists has 362 Employees.(i)
  • Virginia Cancer Specialists grew their employee count by 7% last year.

Virginia Cancer Specialists's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2832.7M101827%N/AN/A
Add Company

What Is Virginia Cancer Specialists?

For the past 40 years, Virginia Cancer Specialists (VCS) has contributed to the campaign against cancer and diseases of the blood. With nine state-of-the-art locations throughout Northern Virginia, VCS is on the cutting-edge of providing patients access to the latest technology, physician collaboration, clinical research, and the most advanced cancer treatments. The dedication of VCS physicians, clinicians and staff to advancing cancer care empowers them to provide top-notch hematology and oncology care and has lead to an expansion into service areas such as radiation, genetics, and bone marrow transplantation. The dedicated and highly-skilled physicians and staff at Virginia Cancer Specialists work closely with patients and their families to create personalized treatment plans that provide for physical and emotional health, all in a familiar community setting. To learn more about VCS, visit www.VirginiaCancerSpecialists.com.

keywords:N/A

N/A

Total Funding

362

Number of Employees

$122.2M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Virginia Cancer Specialists News

2022-04-06 - Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April 8, 2022, at 1:15 PM ET

D., FACP?, Co-Director, Virginia Cancer Specialists Research Institute, Director, Thoracic and Phase 1 Program and RTX-240 clinical investigator...

2022-04-06 - Rubius Therapeutics Reports Updated Clinical Data at AACR from ...

... the Virginia Cancer Specialists Research Institute and the Phase 1 Trial Program, and a clinical investigator in all of Rubius' oncology...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$69.4M3709%N/A
#2
$72.4M3867%N/A
#3
$15M4742%N/A
#4
$130.4M4745%N/A
#5
$170.8M50626%N/A